Consent to Telemedicine and Informed Consent for Medications

Last revised: February 19, 2025

Consent to Telemedicine

Lovely Meds partners with Beluga Health, P.A. (“Beluga”), an independent medical group, to ensure that all prescription products are dispensed only after review by a licensed healthcare provider.

  • As required by law, a provider licensed in your state will review your health information before any prescription medication is dispensed.

  • Most reviews are completed through secure asynchronous messaging, unless state law requires a real-time video consultation.

  • By creating an account with Lovely Meds and checking the consent box, you confirm your informed consent to participate in telemedicine as part of the legal process required for prescription fulfillment.

Informed Consent to Compounded Semaglutide and Compounded Tirzepatide & Safety Information

  • A licensed provider will review your health information to determine if compounded Semaglutide or compounded Tirzepatide is appropriate for you.

  • Important safety information about these and related FDA-approved medications is available on our [Safety Information] page.

  • You are responsible for reviewing these materials and discussing them with your healthcare provider before starting treatment.

By checking the consent box during account creation, you acknowledge and agree that:

  • You have read and understand the potential risks and side effects.

  • You will continue routine medical care with your primary provider for any conditions unrelated to this treatment.

  • Weight loss outcomes are not guaranteed.

  • Compounded medications are not FDA-approved.

  • No refunds will be issued once medication is dispensed.

  • You will provide accurate health information.

  • You will follow dosing instructions and never share needles.

Certification of Consent to Proceed with Treatment

By checking the consent box, you confirm that you understand and accept the risks described above and consent to proceed with treatment using compounded Semaglutide and/or compounded Tirzepatide as determined appropriate by a licensed provider.

Call, Email, and Text Messaging Consent

You consent to Lovely Meds, its affiliated providers, and pharmacy partners contacting you via phone, email, or text (SMS/MMS) regarding your orders, prescription review, and account activity.

  • Communications may be made using an auto-dialer or pre-recorded voice.

  • Standard carrier rates may apply.

  • You may withdraw this consent at any time by emailing hello@lovelymeds.com.

Changes to This Notice

We may update this Consent from time to time. Any updates will be posted on our website.